Results 191 to 200 of about 173,695 (279)

Exploring the immunomodulatory impacts of blood manufacturing consolidation

open access: yesTransfusion, Volume 66, Issue 3, Page 491-506, March 2026.
Abstract Introduction The immunomodulatory consequences of blood transfusion, known as transfusion‐related immune modulation (TRIM), are often not captured by hemovigilance systems. Changes to blood product manufacturing processes may impact patient outcomes.
Amanda Kauffman   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy